You are here: All Products  > Gland Pharma, a Fosun Subsidiary, Plans $650 Million IPO in India

Gland Pharma, a Fosun Subsidiary, Plans $650 Million IPO in India

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products